Comparing Abilify vs Rexulti
| Abilify (aripiprazole) | Rexulti (brexpiprazole) |
|
|---|
| Abilify (aripiprazole) | Rexulti (brexpiprazole) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Abilify is an antipsychotic used to treat schizophrenia, manic and mixed episodes associated with Bipolar disorder, Tourette's Disorder, irritability associated with Autistic disorder, or for the... View more |
Prescription only
Rexulti is an atypical antipsychotic that may be used to treat adults with schizophrenia or depression, or used to relieve agitation associated with dementia in Alzheimer's disease. Most people... View more |
Related suggestions Depression
Major Depressive Disorder
Schizophrenia
|
|||||||||||||||
| More about Abilify (aripiprazole) | More about Rexulti (brexpiprazole) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Abilify has an average rating of 6.1 out of 10 from a total of 1187 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 34% reported a negative effect. |
Rexulti has an average rating of 6.6 out of 10 from a total of 489 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 26% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Abilify side effects |
View all Rexulti side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Abilify prices |
View all Rexulti prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other aripiprazole brands include: Abilify Asimtufii, Abilify Maintena, Abilify MyCite, Aristada, Aristada Initio, Mezofy, Opipza |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
146 hours |
91 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 731 drugs are known to interact with Abilify:
|
A total of 599 drugs are known to interact with Rexulti:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
November 15, 2002 |
July 10, 2015 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.